Latest News Archive
Please select Category, Year, and then Month to display items
07 January 2018
Photo Charl Devenish
Dr Anneke van der Spoel van Dijk is invested in contributing
to the global effort of stopping TB by 2035.
The work of Dr Anneke van der Spoel van Dijk investigates the spread of TB in the Free State population using techniques such as next generation sequencing, spoligotyping and MIRU-VNTR typing. Dr Van der Spoel van Dijk, a senior medical scientist in the Department of Medical Microbiology at the University of the Free State (UFS) also looks at drug resistance in her research. This work informs decisions about how best to treat patients with multidrug-resistant TB (MDR-TB).
She employs rapid molecular techniques to track one of Africa’s most serious diseases, tuberculosis (TB).
Drug resistance
Scientists assist the National Health Laboratory Service and Department of Health in trying to refine the diagnostic tools to identify these cases earlier. Dr Van der Spoel van Dijk explains: “Until recently, it took up to two years to fine-tune treatment decisions for patients with MDR-TB. Patients get a cocktail of anti-TB drugs, but it takes time to find the right combination. Re-infection and relapse (patients stopping treatment for several reasons) add to the diagnostic and treatment management challenges.
Enormous impact
“Now doctors can reduce the time needed for diagnostic certainty to about seven days, while new drugs allow reduction of treatment from more than 18 to nine months. This can have an enormous impact on the life of many patients.”
Dr Van der Spoel van Dijk’s work forms part of research in the faculty looking at resistance development in TB strains. She is currently also doing her doctoral thesis on the differences and incidence of MDR-TB among adolescents versus adults. Dr Van der Spoel van Dijk says: “It is a complicated picture, but we hope to unravel it to support better diagnostic tools and patient care.”
As part of the National Health Laboratory Service, her department is playing an important role in TB diagnostics and the training of scientists and future pathologists. “Our work is contributing to the global vision to stop TB by 2035,” Dr Van der Spoel van Dijk says.
A woman with a vision and dreams
2014-09-19
Louzanne Coetzee recently made Kovsie -history when she became the first blind woman to be elected to the SRC in the portfolio for Student Accessibility and Support. She has not even considered standing for the SRC before, though.
“I wanted to create awareness of disabled students on campus,” Louzanne says. “By running for SRC and this specific portfolio, I thought it would be a great way to do so.” She has a lot of ideas on how to make the portfolio function better and to link the accessibility and support braches of the portfolio.
Louzanne has a passion for leadership. “I think this is a great platform for me to live out my values.” She describes herself as dynamic, but admits that she often pushes herself very hard to achieve the goals she has set out for herself. “I’m also very competitive. But I believe I can make it work to my advantage by setting goals regarding my leadership position on campus to make them happen.”
Having won several gold medals at athletic track events, Louzanne also aims to be selected for the South African 2016 Paralympics team.
And the one dream after another coming true for her, arises from a firm belief in the right attitude.
“I believe that with one’s attitude one can achieve anything. My personal motto has always been ‘mind management is life management’. One of the greatest lessons I have ever learned is that everything is determined by your attitude. The latter determines how you live your life and handle situations.”